The clinical progression of vascular cognitive impairment

Chinese Journal of Clinical Rehabilitation

Volumn 8, Issue 1, 2004, Pages 127-129

  Meng, Chao ^a   Zhang, Xin Qing ^a   Sun, Hou Liang ^a   Wang, H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR DISORDER; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEMENTIA; HUMAN; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; VASCULAR DISEASE;

EID: 2442598175     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Roth M. The natural history of mental disorders in old age. J Ment Sci 1995; 101: 281-301
2. Hachinski VC, Illif LD, Zhilka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 623-7
3. Loeb B. Vascular dementia//Frederiks JAM. Neurobehavioral disorders. Handbook of clinical neurology, vol. 2. Amsterdam: Elsevier 1985:353-69
4. Bowler JV, Hachinski VC. Vascular cognitive impairment: a new approach to vascular dementia//Hachinski V. Cerebrovascular disease. London: Balloere Tindall 1995: 357-60
5. Rockwood K, Howard K, MacKnight C, et al. Spectrum of disease in vascular cognitive impairment. Neuroepidemiology 1999; 18(5): 248-54
6. Chinese source. 2003,7(28):3852-3
7. Desmond DW, Moroney JT, Paik MC, et al. Frequency and clinical determinants of dementia after ischemic, stroke. Neurology, 2000; 54: 1124-31
8. Madureira S, Guerreiro M, Ferro JM. Dementia and cognitive impairment three months after stroke. Eur J Neurol 2001; 8(6): 621-7
9. Chinese source. 1999, 16(6): 367-8
10. Chinese source. 2003,7(7): 1090-1
11. Chinese source. 2003, 7(3): 409
12. Benke T, Neusal D, Aichner F. Neuropsychological deficits in asymptomatic carotid artery stenosis. Acta Neurol Scand 1991; 83: 378-81
13. Incalzi RA, Gemma A, Landi F, et al. Neuropsychologic effects of carotid endarterectomy. J Clin Neuropsychol 1997; 19: 785-94
14. Yu PH. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer' a disease and vascular dementia. Med Hypotheses 2001; 57(2): 175-9
15. Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999:67(1):66-72
16. Broderick JP, Gaskill M, Dhawan A, et al. Temporal changes in brain volume and cognition in a randomized treatment trial of vascular dementia. J Neuroimaging 2001; 11(1): 6-12
17. Fein G, Sclafani VD, Tanabe J, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic, vascular disease. Neurology 2000; 55: 1626-35
18. Levasseur M, Baron JC, Sette, G, et al. Brain energy metabolism in bilateral paramedian thalamic infarcts. A position emission tomography study. Brain 1992; 115: 795-807
19. Tatemichi TK, Desmond DW, Prohocnik I. Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology 1992; 42: 1966-79
20. Laplane D, Levasseur M, Pillon B, et al. Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. Brain 1989; 112: 699-725
21. Chabriat H, Pappata S, Levasseur M, et al. Cortical metabolism in posterolateral thalamic stroke: PET study. Acta Neurol Scand 1992; 86: 283-90
22. Weiller C, Chollet F, Foiston KJ, et al. Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann Neurol 1997; 31: 463-72
23. Meguro K, Hatazawa J, Yamaguchi T, et al, Cerebral circulation and oxygen metabolism associated with subclinical periventricular hypertensity as shown by magnetic resonance imaging. Ann Neurol 1990; 28: 378-83
24. Sabri O, Ringelstein EB, Hellwig D. et al. Neuropsychological impairments correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke 1999; 30: 556-66
25. Fredman P, Wallin A, Blennow K, et al. Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia. Acta Neurol Scand 1992; 85: 103-6
26. Blennow K, Wallin A, Ekmen R. Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders? J Neurol Transm Park Dis Dementia Sect 1994; 8: 183-91
27. Rosengren LE, Karllson JE, Sjogren M, et al. Neurofilament protein levels in CSF are increased in dementia. Neurology 1999; 52: 1090-3
28. Chui HC, Mack W, Jackson JE, et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol 2000; 57 (2): 191-6
29. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the non-demented elderly: results from the Canadian Study of Health and Aging. Arch Neurol 1995; 52: 612-19
30. Wentzel C, Rockwood K, MacKnight C, et al. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001; 57(4): 714-6